|
|
Article: A Report on Biosimilars as a Viable Market, as the Future of the Pharmaceutical Market Lies with Biotechnology.
- Article from:
- M2 Presswire
- Article date:
- September 26, 2008
CopyrightCOPYRIGHT 2008 M2 Communications Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
M2 PRESSWIRE-26 September 2008-Research and Markets: A Report on Biosimilars as a Viable Market, as the Future of the Pharmaceutical Market Lies with Biotechnology(C)1994-2008 M2 COMMUNICATIONS LTD
RDATE:26092008
Dublin - Research and Markets (http://www.researchandmarkets.com/research/619c10/biosimilars_a_via) has announced the addition of the "Biosimilars: A Viable Market - But When?" report to their offering.
Providing
A thorough review of the latest regulatory situation in the USA, Europe and selected markets
An examination of products that are currently available for development:
- EPO